Select Medical (SEM) Stock Forecast, Price Target & Predictions
SEM Stock Forecast
Select Medical stock forecast is as follows: an average price target of $40.00 (represents a 104.08% upside from SEM’s last price of $19.60) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
SEM Price Target
The average price target for Select Medical (SEM) is $40.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $40.00 to $40.00. This represents a potential 104.08% upside from SEM's last price of $19.60.
SEM Analyst Ratings
According to 3 Wall Street analysts, Select Medical's rating consensus is 'Buy'. The analyst rating breakdown for SEM stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Select Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Frank Morgan | RBC Capital | $40.00 | $31.43 | 27.27% | 104.08% |
The latest Select Medical stock forecast, released on May 06, 2024 by Frank Morgan from RBC Capital, set a price target of $40.00, which represents a 27.27% increase from the stock price at the time of the forecast ($31.43), and a 104.08% increase from SEM last price ($19.60).
Select Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $40.00 |
| Last Closing Price | $19.60 | $19.60 | $19.60 |
| Upside/Downside | -100.00% | -100.00% | 104.08% |
In the current month, the average price target of Select Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Select Medical's last price of $19.60. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 03, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Aug 20, 2024 | Benchmark | Buy | Buy | Hold |
| Aug 20, 2024 | Benchmark Co. | Underperform | Underperform | Hold |
| Jul 16, 2024 | Benchmark | Underperform | Underperform | Hold |
| Jul 16, 2024 | RBC Capital | Buy | Buy | Hold |
| Jul 16, 2024 | Benchmark | Buy | Buy | Hold |
| May 06, 2024 | Benchmark | Buy | Buy | Hold |
| May 06, 2024 | RBC Capital | Outperform | Outperform | Hold |
Select Medical's last stock rating was published by Bank of America Securities on Dec 03, 2024. The company gave SEM a "Buy" rating, the same as its previous rate.
Select Medical Financial Forecast
Select Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.67B | $1.67B | $1.66B | $1.58B | $1.57B | $1.58B | $1.60B | $1.56B | $1.53B | $1.56B | $1.55B | $1.46B | $1.42B | $1.23B | $1.41B | $1.37B | $1.39B |
| Avg Forecast | $1.45B | $1.42B | $1.44B | $1.47B | $1.34B | $1.32B | $1.34B | $1.37B | $1.28B | $1.74B | $1.74B | $1.74B | $1.64B | $1.63B | $1.65B | $1.65B | $1.58B | $1.56B | $1.58B | $1.56B | $1.52B | $1.44B | $1.44B | $1.44B | $1.41B | $1.37B | $1.15B | $1.36B | $1.34B | $1.31B |
| High Forecast | $1.62B | $1.58B | $1.60B | $1.63B | $1.49B | $1.47B | $1.49B | $1.52B | $1.43B | $1.74B | $1.74B | $1.74B | $1.82B | $1.65B | $1.83B | $1.83B | $1.68B | $1.56B | $1.58B | $1.56B | $1.52B | $1.44B | $1.44B | $1.44B | $1.41B | $1.37B | $1.15B | $1.36B | $1.34B | $1.31B |
| Low Forecast | $1.37B | $1.34B | $1.36B | $1.38B | $1.26B | $1.25B | $1.26B | $1.29B | $1.21B | $1.73B | $1.74B | $1.74B | $1.54B | $1.59B | $1.55B | $1.55B | $1.36B | $1.56B | $1.58B | $1.56B | $1.52B | $1.44B | $1.44B | $1.44B | $1.41B | $1.37B | $1.15B | $1.36B | $1.34B | $1.31B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.02% | 1.01% | 1.00% | 1.01% | 1.00% | 1.02% | 1.02% | 1.06% | 1.09% | 1.07% | 1.04% | 1.04% | 1.07% | 1.04% | 1.03% | 1.06% |
Select Medical's average Quarter revenue forecast for Dec 23 based on 2 analysts is $1.64B, with a low forecast of $1.54B, and a high forecast of $1.82B. SEM's average Quarter revenue forecast represents a -1.60% decrease compared to the company's last Quarter revenue of $1.67B (Sep 23).
Select Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.46B | $219.64M | $212.44M | $145.87M | $151.01M | $178.22M | $160.42M | $141.33M | $188.55M | $315.42M | $239.63M | $199.37M | $192.64M | $164.62M | $172.90M | $140.11M | $150.86M |
| Avg Forecast | $169.87M | $166.26M | $168.45M | $171.45M | $156.37M | $154.73M | $156.20M | $160.15M | $150.00M | $203.02M | $203.93M | $209.15M | $191.61M | $190.16M | $192.30M | $190.13M | $112.69M | $203.31M | $206.30M | $172.85M | $198.44M | $188.19M | $187.25M | $157.14M | $183.99M | $178.19M | $150.57M | $145.88M | $174.14M | $171.24M |
| High Forecast | $189.02M | $185.00M | $187.44M | $190.78M | $173.99M | $172.17M | $173.81M | $178.20M | $166.91M | $203.26M | $203.93M | $250.98M | $213.20M | $192.96M | $213.97M | $228.16M | $135.23M | $203.31M | $206.30M | $207.42M | $198.44M | $188.19M | $187.25M | $188.56M | $183.99M | $178.19M | $150.57M | $175.06M | $174.14M | $171.24M |
| Low Forecast | $160.01M | $156.61M | $158.67M | $161.50M | $147.29M | $145.75M | $147.14M | $150.85M | $141.30M | $202.77M | $203.93M | $167.32M | $180.48M | $186.19M | $181.13M | $152.11M | $90.15M | $203.31M | $206.30M | $138.28M | $198.44M | $188.19M | $187.25M | $125.71M | $183.99M | $178.19M | $150.57M | $116.70M | $174.14M | $171.24M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.66% | 1.14% | 1.12% | 1.29% | 0.74% | 0.86% | 0.93% | 0.71% | 1.00% | 1.68% | 1.53% | 1.08% | 1.08% | 1.09% | 1.19% | 0.80% | 0.88% |
2 analysts predict SEM's average Quarter EBITDA for Dec 23 to be $191.61M, with a high of $213.20M and a low of $180.48M. This is -86.84% lower than Select Medical's previous annual EBITDA (Sep 23) of $1.46B.
Select Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $48.18M | $78.24M | $70.81M | $37.71M | $38.13M | $55.21M | $49.12M | $66.31M | $76.93M | $164.89M | $110.55M | $77.27M | $76.95M | $51.65M | $53.13M | $32.07M | $30.73M |
| Avg Forecast | $43.68M | $28.59M | $46.26M | $38.53M | $30.52M | $25.61M | $33.72M | $45.77M | $21.62M | $27.89M | $40.64M | $96.48M | $23.06M | $27.31M | $36.21M | $87.71M | $44.23M | $55.80M | $68.32M | $79.74M | $37.83M | $64.80M | $69.16M | $72.49M | $44.38M | $36.19M | $2.18M | $44.82M | $23.12M | $25.80M |
| High Forecast | $50.09M | $32.77M | $53.04M | $44.18M | $34.99M | $29.37M | $38.66M | $52.47M | $27.39M | $31.98M | $46.60M | $115.78M | $24.55M | $28.64M | $41.51M | $105.25M | $53.07M | $55.80M | $68.32M | $95.69M | $37.83M | $64.80M | $69.16M | $86.99M | $44.38M | $36.19M | $2.18M | $53.79M | $23.12M | $25.80M |
| Low Forecast | $40.39M | $26.43M | $42.77M | $35.62M | $28.21M | $23.68M | $31.18M | $42.31M | $15.86M | $25.79M | $37.58M | $77.19M | $21.57M | $25.31M | $33.48M | $70.17M | $35.38M | $55.80M | $68.32M | $63.79M | $37.83M | $64.80M | $69.16M | $57.99M | $44.38M | $36.19M | $2.18M | $35.86M | $23.12M | $25.80M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.76% | 2.16% | 0.81% | 0.85% | 0.68% | 0.81% | 0.62% | 1.75% | 1.19% | 2.38% | 1.53% | 1.74% | 2.13% | 23.66% | 1.19% | 1.39% | 1.19% |
Select Medical's average Quarter net income forecast for Dec 23 is $23.06M, with a range of $21.57M to $24.55M. SEM's average Quarter net income forecast represents a -52.14% decrease compared to the company's last Quarter net income of $48.18M (Sep 23).
Select Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $41.32M | $42.51M | $42.28M | $38.76M | $39.49M | $37.27M | $37.51M | $37.95M | $37.88M | $35.74M | $35.40M | $35.23M | $35.52M | $33.46M | $33.83M | $34.06M | $34.38M |
| Avg Forecast | $35.43M | $34.68M | $35.13M | $35.76M | $32.61M | $32.27M | $32.58M | $33.40M | $31.28M | $42.34M | $42.53M | $44.51M | $39.96M | $39.66M | $40.10M | $40.47M | $33.67M | $38.01M | $38.57M | $36.79M | $37.10M | $35.18M | $35.01M | $33.44M | $34.40M | $33.32M | $28.15M | $28.54M | $32.56M | $32.02M |
| High Forecast | $39.42M | $38.58M | $39.09M | $39.79M | $36.29M | $35.91M | $36.25M | $37.16M | $34.81M | $42.39M | $42.53M | $53.42M | $44.46M | $40.24M | $44.62M | $48.56M | $40.40M | $38.01M | $38.57M | $44.15M | $37.10M | $35.18M | $35.01M | $40.13M | $34.40M | $33.32M | $28.15M | $34.25M | $32.56M | $32.02M |
| Low Forecast | $33.37M | $32.66M | $33.09M | $33.68M | $30.72M | $30.40M | $30.69M | $31.46M | $29.47M | $42.29M | $42.53M | $35.61M | $37.64M | $38.83M | $37.78M | $32.37M | $26.93M | $38.01M | $38.57M | $29.43M | $37.10M | $35.18M | $35.01M | $26.76M | $34.40M | $33.32M | $28.15M | $22.84M | $32.56M | $32.02M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.06% | 1.04% | 1.15% | 1.04% | 0.97% | 1.02% | 1.02% | 1.08% | 1.02% | 1.06% | 1.02% | 1.07% | 1.19% | 1.19% | 1.05% | 1.07% |
Select Medical's average Quarter SG&A projection for Dec 23 is $39.96M, based on 2 Wall Street analysts, with a range of $37.64M to $44.46M. The forecast indicates a -3.28% fall compared to SEM last annual SG&A of $41.32M (Sep 23).
Select Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 7 | 7 | 9 | 8 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.38 | $0.61 | $0.70 | $0.25 | $0.31 | $0.43 | $0.37 | $0.51 | $0.59 | $1.26 | $0.85 | $0.59 | $0.80 | $0.40 | $0.41 | $0.33 | $0.34 |
| Avg Forecast | $0.35 | $0.23 | $0.37 | $0.31 | $0.24 | $0.21 | $0.27 | $0.37 | $0.17 | $0.22 | $0.33 | $0.31 | $0.18 | $0.22 | $0.29 | $0.23 | $0.36 | $0.45 | $0.55 | $0.28 | $0.31 | $0.52 | $0.56 | $0.61 | $0.36 | $0.29 | $0.02 | $0.32 | $0.19 | $0.21 |
| High Forecast | $0.40 | $0.26 | $0.43 | $0.35 | $0.28 | $0.24 | $0.31 | $0.42 | $0.22 | $0.26 | $0.37 | $0.35 | $0.20 | $0.23 | $0.33 | $0.26 | $0.39 | $0.45 | $0.55 | $0.28 | $0.31 | $0.52 | $0.56 | $0.61 | $0.36 | $0.29 | $0.02 | $0.32 | $0.19 | $0.21 |
| Low Forecast | $0.32 | $0.21 | $0.34 | $0.29 | $0.23 | $0.19 | $0.25 | $0.34 | $0.13 | $0.21 | $0.30 | $0.28 | $0.17 | $0.20 | $0.27 | $0.21 | $0.29 | $0.45 | $0.55 | $0.28 | $0.31 | $0.52 | $0.56 | $0.61 | $0.36 | $0.29 | $0.02 | $0.32 | $0.19 | $0.21 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.74% | 2.10% | 3.09% | 0.69% | 0.69% | 0.78% | 1.34% | 1.67% | 1.13% | 2.26% | 1.40% | 1.65% | 2.74% | 22.71% | 1.30% | 1.77% | 1.63% |
According to 2 Wall Street analysts, Select Medical's projected average Quarter EPS for Dec 23 is $0.18, with a low estimate of $0.17 and a high estimate of $0.20. This represents a -51.34% decrease compared to SEM previous annual EPS of $0.38 (Sep 23).
Select Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SEM | Select Medical | $19.60 | $40.00 | 104.08% | Buy |
| ACHC | Acadia Healthcare | $43.74 | $81.50 | 86.33% | Buy |
| INNV | InnovAge | $3.73 | $6.80 | 82.31% | Hold |
| PNTG | Pennant Group | $27.51 | $34.67 | 26.03% | Buy |
| ENSG | Ensign Group | $140.58 | $167.33 | 19.03% | Buy |
| ADUS | Addus HomeCare | $126.27 | $146.20 | 15.78% | Buy |
| EHAB | Enhabit | $8.40 | $9.50 | 13.10% | Hold |
| EHC | Encompass Health | $95.57 | $107.50 | 12.48% | Buy |
| MD | Pediatrix Medical Group | $14.19 | $13.50 | -4.86% | Hold |